Haemonetics Corporation is a company in the U.S. stock market and it is a holding in 93 U.S.-traded ETFs. HAE has around 4.8M shares in the U.S. ETF market. The largest ETF holder of HAE is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 1.34M shares. Investors may also find of interest that the ETF with the largest allocation to HAE stock is Invesco S&P Midcap Quality ETF (XMHQ), with a portfolio weight of 1.37%. On average, U.S. ETFs allocate 0.16% of HAE to their portfolios.

Additionally, HAE is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with HAE as a holding is the ProShares Ultra Health Care (RXL), with a return of 26.71%.